{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:48:23Z","timestamp":1790358503669,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,8]],"date-time":"2018-07-08T00:00:00Z","timestamp":1531008000000},"content-version":"am","delay-in-days":280,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AVID Radiopharmaceuticals"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AG024904"],"award-info":[{"award-number":["U01 AG024904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-12-2-0012"],"award-info":[{"award-number":["W81XWH-12-2-0012"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007742","name":"BioClinica, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006314","name":"Biogen Idec Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Elan Pharmaceuticals, Inc"},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005061","name":"Innogenetics, N.V.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005061","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IXICO Ltd"},{"name":"Janssen Alzheimer Immunotherapy Research & Development, LLC."},{"name":"Johnson & Johnson Pharmaceutical Research & Development LLC."},{"DOI":"10.13039\/100007050","name":"Medpace, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck & Co, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics, LLC.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NeuroRx Research"},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Piramal Imaging"},{"name":"Servier"},{"DOI":"10.13039\/100007141","name":"Synarc Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.neurobiolaging.2017.06.002","type":"journal-article","created":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T17:30:32Z","timestamp":1497893432000},"page":"14-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"special_numbering":"C","title":["Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease"],"prefix":"10.1016","volume":"58","author":[{"given":"Joana B.","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Westman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.mri.2009.01.006","article-title":"Computational anatomy with the SPM software","volume":"27","author":"Ashburner","year":"2009","journal-title":"Magn. Res. Imaging"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.neuron.2016.07.007","article-title":"Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases","volume":"91","author":"Bacioglu","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib3","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1212\/01.wnl.0000340981.97664.2f","article-title":"The cortical signature of prodromal AD Regional thinning predicts mild AD dementia","volume":"72","author":"Bakkour","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib4","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3233\/JAD-150732","article-title":"Detection of striatal amyloid plaques with [18F] flutemetamol: validation with postmortem histopathology","volume":"52","author":"Beach","year":"2016","journal-title":"JAD"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib5","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/mds.26656","article-title":"Cerebrospinal fluid biomarkers in alzheimer's and parkinson's diseases-from pathophysiology to clinical practice","volume":"31","author":"Blennow","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/BF01273157","article-title":"Synaptic pathology in alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele","volume":"103","author":"Blennow","year":"1996","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF markers for incipient alzheimer's disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib10","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.neuron.2012.11.021","article-title":"The neuropathology and neurobiology of traumatic brain injury","volume":"76","author":"Blennow","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib11","first-page":"34","article-title":"Pattern of Tau forms in CSF is altered in progressive supranuclear palsy","volume":"30","author":"Borroni","year":"2009","journal-title":"Neurobiology"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib12","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.neuroimage.2004.06.018","article-title":"A\u00a0unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: Reliability and validation against manual measurement of total intracranial volume","volume":"23","author":"Buckner","year":"2004","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib13","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1523\/JNEUROSCI.5062-08.2009","article-title":"Cortical hubs revealed by intrinsic functional connectivity: Mapping, assessment of stability, and relation to alzheimer's disease","volume":"29","author":"Buckner","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib14","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","article-title":"Molecular, structural, and functional characterization of alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory","volume":"25","author":"Buckner","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib15","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/00005072-199710000-00004","article-title":"Dendritic translocation of RC3\/neurogranin mRNA in normal aging, alzheimer disease and fronto-temporal dementia","volume":"56","author":"Chang","year":"1997","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuron.2008.02.003","article-title":"Endocytosis is required for synaptic activity-dependent release of amyloid-\u03b2 in\u00a0vivo","volume":"58","author":"Cirrito","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib17","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","article-title":"Synaptic activity regulates interstitial fluid amyloid-\u03b2 levels in\u00a0vivo","volume":"48","author":"Cirrito","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib18","doi-asserted-by":"crossref","first-page":"13848","DOI":"10.1073\/pnas.0601417103","article-title":"Consistent resting-state networks across healthy subjects","volume":"103","author":"Damoiseaux","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1017\/S1041610298005110","article-title":"Neurochemical dissection of synaptic pathology in Alzheimer's disease","volume":"10","author":"Davidsson","year":"1998","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib20","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/jamaneurol.2016.0090","article-title":"Cerebrospinal biomarkers in alzheimer disease-potential roles as markers of prognosis and neuroplasticity","volume":"73","author":"DeKosky","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/cercor\/bhn113","article-title":"The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals","volume":"19","author":"Dickerson","year":"2009","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1212\/WNL.0b013e31823efc6c","article-title":"MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults","volume":"78","author":"Dickerson","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib23","doi-asserted-by":"crossref","first-page":"11050","DOI":"10.1073\/pnas.200033797","article-title":"Measuring the thickness of the human cerebral cortex from magnetic resonance images","volume":"97","author":"Fischl","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","article-title":"Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain","volume":"33","author":"Fischl","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib25","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1523\/JNEUROSCI.3785-09.2010","article-title":"CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease","volume":"30","author":"Fjell","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.48.1.132","article-title":"Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm","volume":"48","author":"Fratiglioni","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib27","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jamaneurol.2016.2642","article-title":"Longitudinal \u03b2-amyloid deposition and hippocampal volume in preclinical alzheimer disease and suspected non\u2013alzheimer disease pathophysiology","volume":"73","author":"Gordon","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib28","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1073\/pnas.0308627101","article-title":"Default-mode network activity distinguishes alzheimer's disease from healthy aging: evidence from functional MRI","volume":"101","author":"Greicius","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib30","first-page":"10","article-title":"Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder","volume":"8","author":"Hansson","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3233\/JAD-2000-23-402","article-title":"Cerebrospinal fluid markers for alzheimer's disease evaluated after acute ischemic stroke","volume":"2","author":"Hesse","year":"2000","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib32","doi-asserted-by":"crossref","first-page":"10660","DOI":"10.1523\/JNEUROSCI.2213-04.2004","article-title":"Neurogranin\/RC3 enhances long-term potentiation and learning by promoting calcium-mediated signaling","volume":"24","author":"Huang","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neurobiolaging.2016.09.012","article-title":"CSF neurofilament light levels predict hippocampal atrophy in cognitively healthy older adults","volume":"49","author":"Idland","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib33","first-page":"2701","article-title":"Regional analysis of striatal and cortical amyloid deposition in patients with Alzheimer's disease","volume":"40","author":"Ishibashi","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib80","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/acn3.266","article-title":"Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of alzheimer's disease","volume":"3","author":"Janelidze","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib36","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jamaneurol.2015.1867","article-title":"Neurogranin as a cerebrospinal fluid biomarker for synaptic loss in symptomatic alzheimer disease","volume":"72","author":"Kester","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib37","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neuroimage.2005.03.036","article-title":"Automated 3-D extraction and evaluation of the inner and outer cortical surfaces using a Laplacian map and partial volume effect classification","volume":"27","author":"Kim","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib38","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib39","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ana.23816","article-title":"Brain injury biomarkers are not dependent on \u03b2-amyloid in normal elderly","volume":"73","author":"Knopman","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib40","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jalz.2014.10.009","article-title":"Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease","volume":"11","author":"Kvartsberg","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib41","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","article-title":"Neurodegenerative tauopathies","volume":"24","author":"Lee","year":"2001","journal-title":"Ann. Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00418-013-1101-1","article-title":"Review on intermediate filaments of the nervous system and their pathological alterations","volume":"140","author":"Lepinoux-Chambaud","year":"2013","journal-title":"Histochem. Cell. Biol."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib43","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1249\/MSS.0b013e31822cf717","article-title":"Cardiorespiratory fitness as a predictor of dementia mortality in men and women","volume":"44","author":"Liu","year":"2012","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib44","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1212\/WNL.0b013e318295d6cf","article-title":"Application of the National Institute on aging\u2013Alzheimer's association AD criteria to adni","volume":"80","author":"Lowe","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib45","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1006\/nimg.1999.0534","article-title":"Automated 3-D extraction of inner and outer surfaces of cerebral cortex from MRI","volume":"12","author":"MacDonald","year":"2000","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib46","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.15252\/emmm.201606540","article-title":"Cerebrospinal fluid tau, neurogranin, and neurofilament light in alzheimer's disease","volume":"8","author":"Mattsson","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib47","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease report of the NINCDS-ADRDA Work group* under the auspices of Department of Health and human Services Task Force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib48","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1212\/WNL.58.2.209","article-title":"Incidence of AD may decline in the early 90s for men, later for women: the Cache County study","volume":"58","author":"Miech","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/CLEP.S37929","article-title":"Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences","volume":"6","author":"Mielke","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib50","first-page":"44","article-title":"Increased CSF tau protein in corticobasal degeneration","volume":"245","author":"Mitani","year":"1997","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fninf.2013.00049","article-title":"TheHiveDB image data management and analysis framework","volume":"7","author":"Muehlboeck","year":"2014","journal-title":"Front. Neuroinform"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib53","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1212\/01.wnl.0000242732.06714.0f","article-title":"Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury","volume":"67","author":"Ost","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib54","first-page":"566","article-title":"S-100 protein concentration in the cerebrospinal fluid of patients with creutzfeldt-jakob disease","volume":"244","author":"Otto","year":"1997","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib55","doi-asserted-by":"crossref","first-page":"11232","DOI":"10.1073\/pnas.210184697","article-title":"Involvement of neurogranin in the modulation of calcium\/calmodulin-dependent protein kinase II, synaptic plasticity, and spatial learning: a study with knockout mice","volume":"97","author":"Pak","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib56","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neuroimage.2009.03.076","article-title":"Morphological alterations in the congenital blind based on the analysis of cortical thickness and surface area","volume":"47","author":"Park","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib81","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1002\/hbm.21378","article-title":"Assessment of cortical degeneration in patients with Parkinson's disease by voxel-based morphometry, cortical folding, and cortical thickness","volume":"33","author":"Pereira","year":"2012","journal-title":"Human Brain Mapp"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib82","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jns.2005.03.015","article-title":"Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss","volume":"233","author":"Petzold","year":"2005","journal-title":"J. Neurol. Sci"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib57","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1093\/brain\/awv267","article-title":"Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in alzheimer's disease","volume":"138","author":"Portelius","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib58","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3233\/JAD-2005-7203","article-title":"Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction","volume":"7","author":"Reddy","year":"2005","journal-title":"JAD"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib59","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1212\/WNL.58.11.1622","article-title":"Tau and A\u03b242 protein in CSF of patients with frontotemporal degeneration","volume":"58","author":"Riemenschneider","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib60","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1212\/WNL.0000000000000055","article-title":"Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal","volume":"82","author":"Roberts","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib61","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1212\/WNL.0000000000003154","article-title":"Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia","volume":"87","author":"Rohrer","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib83","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer's disease","volume":"141","author":"Rosen","year":"1984","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib62","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0197-4580(01)00231-7","article-title":"Incidence of dementia: does gender make a difference?","volume":"22","author":"Ruitenberg","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib63","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/01.wnl.0000260698.46517.8f","article-title":"Synaptic alterations in CA1 in mild alzheimer disease and mild cognitive impairment","volume":"68","author":"Scheff","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib84","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.neuroimage.2004.03.032","article-title":"A hybrid approach to the skull stripping problem in MRI","volume":"22","author":"S\u00e9gonne","year":"2004","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib85","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1109\/TMI.2006.887364","article-title":"Geometrically accurate topology-correction of cortical surfaces using nonseparating loops","volume":"26","author":"S\u00e9gonne","year":"2007","journal-title":"IEEE Trans. Med. Imaging"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib64","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer's disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib65","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nm0706-758","article-title":"The ups and downs of A [beta]","volume":"12","author":"Selkoe","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib66","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in alzheimer's disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib86","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1212\/WNL.0000000000001015","article-title":"CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival","volume":"83","author":"Skillb\u00e4ck","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib87","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1109\/42.668698","article-title":"A nonparametric method for automatic correction of intensity nonuniformity in MRI data","volume":"17","author":"Sled","year":"1998","journal-title":"IEEE Trans. Med. Imaging"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib67","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/jamaneurol.2016.0086","article-title":"Diagnostic and prognostic utility of the synaptic marker neurogranin in alzheimer disease","volume":"73","author":"Tarawneh","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib68","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in alzheimer's disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib69","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.15252\/emmm.201606801","article-title":"New CSF biomarkers on the block","volume":"8","author":"Teunissen","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib70","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1523\/JNEUROSCI.23-03-00994.2003","article-title":"Dynamics of gray matter loss in Alzheimer's disease","volume":"23","author":"Thompson","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib71","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.neurobiolaging.2010.04.030","article-title":"Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study","volume":"31","author":"Tosun","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib72","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1523\/JNEUROSCI.06-03-00650.1986","article-title":"Expression of neurofilament subunits in neurons of the central and peripheral nervous system: an immunohistochemical study with monoclonal antibodies","volume":"6","author":"Trojanowski","year":"1986","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib73","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/JGP.0b013e3181faec23","article-title":"Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study","volume":"19","author":"Tschanz","year":"2011","journal-title":"Am. J. Geriat. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib74","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.neuroimage.2008.08.013","article-title":"Evidence for abnormalities of cortical development in adolescent-onset schizophrenia","volume":"43","author":"Voets","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib75","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1212\/WNL.0000000000002423","article-title":"Increased CSF neurogranin concentration is specific to alzheimer disease","volume":"86","author":"Wellington","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib76","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/mp.2015.45","article-title":"Neurofilament subunits are integral components of synapses and modulate neurotransmission and behavior in\u00a0vivo","volume":"20","author":"Yuan","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib77","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jamaneurol.2015.2075","article-title":"Neurogranin levels in cerebrospinal fluid: a new addition to the alzheimer disease diagnostic toolbox","volume":"72","author":"Zetterberg","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib78","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1468-1331.2007.01972.x","article-title":"Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: Impact of SOD1 genotype","volume":"14","author":"Zetterberg","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.06.002_bib79","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaneurol.2015.3037","article-title":"Association of cerebrospinal fluid neurofilament light concentration with alzheimer disease progression","volume":"73","author":"Zetterberg","year":"2016","journal-title":"JAMA Neurol."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458017301987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458017301987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:24:37Z","timestamp":1759317877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458017301987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":86,"alternative-id":["S0197458017301987"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.06.002","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}